NCT03737279 (Meditate) is a NA clinical trial of Meditation in Pregnancy, High Risk, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT03737279?

NCT03737279 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT03737279?

Interventions in NCT03737279: Meditation, Routine Care.

What condition does NCT03737279 study?

NCT03737279 studies Pregnancy, High Risk, Pregnancy Related.

Is NCT03737279 still recruiting?

NCT03737279 is currently completed. Last updated 16 June 2020.

Last reviewed 2020-06-16 · How we verify

NCT03737279: Meditate

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Daily Meditation Program in Women Admitted to the Antepartum Unit

Completed NA Last updated 16 June 2020

What this trial tests

NA trial testing Meditation in Pregnancy, High Risk in 56 participants. Completed in 1 April 2020.

Timeline

4 March 2019

Primary endpoint
1 April 2020

1 April 2020

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	56
Start date	4 March 2019
Primary completion	1 April 2020
Estimated completion	1 April 2020
Sites	1 location across United States

Drugs / interventions tested

Meditation
Routine Care

Conditions studied

Pregnancy, High Risk — all drugs for Pregnancy, High Risk →
Pregnancy Related — all drugs for Pregnancy Related →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

18 and older, female only, with Pregnancy, High Risk or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess whether a daily mindful meditation program for women admitted to the antepartum floor will decrease maternal state anxiety compared to routine care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Daily meditation program for anxiety in individuals admitted to the antepartum unit: a multicenter randomized controlled trial (MEDITATE).
Doty MS, Chen HY, Ajishegiri O, Sibai BM, et al · · 2022 · cited 7× · PMID 35031521 · DOI 10.1016/j.ajogmf.2022.100562

Verify or expand the search:

Other trials of Meditation

Trials testing the same drug.

NCT07534683 — Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological an · NA · not yet recruiting
NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
NCT07310992 — Effect of Meditation as an Adjunct to Cardiac Rehabilitation · NA · not yet recruiting
NCT07176013 — Immersive Virtual Reality Meditation in Voice Therapy · NA · enrolling by invitation
NCT06866288 — Belongingness in Nursing Through Mindfulness - BEING Mindful: A Pilot Study · NA · completed

Other recruiting trials for Pregnancy, High Risk

Currently open trials in the same condition.

NCT05388643 — Early Detection of Gestational Diabetes Mellitus in Pregnancy · NA · recruiting
NCT06654713 — Commercial or Open Source Closed Loop Impact on Pregnancy Study · recruiting
NCT05317585 — Continuous Glucose Monitor Use in Pregnancy · NA · recruiting
NCT05790252 — Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE) · Phase 3 · recruiting
NCT05909046 — A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE · NA · recruiting

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03737279 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 16 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03737279.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing